User menu

Safety of treatment of uterine fibroids with the selective progesterone receptor modulator, ulipristal acetate

Bibliographic reference Donnez, Jacques ; Donnez, Olivier ; Dolmans, Marie-Madeleine. Safety of treatment of uterine fibroids with the selective progesterone receptor modulator, ulipristal acetate. In: Expert Opinion on Drug Safety, Vol. 15, no.12, p. 1679-1686 (2016)
Permanent URL http://hdl.handle.net/2078.1/180163
  1. Kim J. Julie, Sefton Elizabeth C., The role of progesterone signaling in the pathogenesis of uterine leiomyoma, 10.1016/j.mce.2011.05.044
  2. Donnez J, Hum Reprod Update (2016)
  3. Biglia N, Drug Des Devel Ther, 20, 285 (2014)
  4. Chabbert-Buffet Nathalie, Meduri Geri, Bouchard Philippe, Spitz Irving M., Selective progesterone receptor modulators and progesterone antagonists: mechanisms of action and clinical applications, 10.1093/humupd/dmi002
  5. Nieman LK, Fertil Steril (2011)
  6. Donnez Jacques, Tatarchuk Tetyana F., Bouchard Philippe, Puscasiu Lucian, Zakharenko Nataliya F., Ivanova Tatiana, Ugocsai Gyula, Mara Michal, Jilla Manju P., Bestel Elke, Terrill Paul, Osterloh Ian, Loumaye Ernest, Ulipristal Acetate versus Placebo for Fibroid Treatment before Surgery, 10.1056/nejmoa1103182
  7. Donnez Jacques, Tomaszewski Janusz, Vázquez Francisco, Bouchard Philippe, Lemieszczuk Boguslav, Baró Francesco, Nouri Kazem, Selvaggi Luigi, Sodowski Krzysztof, Bestel Elke, Terrill Paul, Osterloh Ian, Loumaye Ernest, Ulipristal Acetate versus Leuprolide Acetate for Uterine Fibroids, 10.1056/nejmoa1103180
  8. Donnez Jacques, Vázquez Francisco, Tomaszewski Janusz, Nouri Kazem, Bouchard Philippe, Fauser Bart C.J.M., Barlow David H., Palacios Santiago, Donnez Olivier, Bestel Elke, Osterloh Ian, Loumaye Ernest, Long-term treatment of uterine fibroids with ulipristal acetate☆, 10.1016/j.fertnstert.2014.02.008
  9. Donnez Jacques, Hudecek Robert, Donnez Olivier, Matule Dace, Arhendt Hans-Joachim, Zatik Janos, Kasilovskiene Zaneta, Dumitrascu Mihai Cristian, Fernandez Hervé, Barlow David H., Bouchard Philippe, Fauser Bart C.J.M., Bestel Elke, Terrill Paul, Osterloh Ian, Loumaye Ernest, Efficacy and safety of repeated use of ulipristal acetate in uterine fibroids, 10.1016/j.fertnstert.2014.10.038
  10. Donnez Jacques, Donnez Olivier, Matule Dace, Ahrendt Hans-Joachim, Hudecek Robert, Zatik Janos, Kasilovskiene Zaneta, Dumitrascu Mihai Cristian, Fernandez Hervé, Barlow David H., Bouchard Philippe, Fauser Bart C.J.M., Bestel Elke, Loumaye Ernest, Long-term medical management of uterine fibroids with ulipristal acetate, 10.1016/j.fertnstert.2015.09.032
  11. Donnez Jacques, Dolmans Marie-Madeleine, Ovarian tissue freezing : current status, 10.1097/gco.0000000000000171
  12. Bouchard Philippe, Chabbert-Buffet Nathalie, Fauser Bart C.J.M., Selective progesterone receptor modulators in reproductive medicine: pharmacology, clinical efficacy and safety, 10.1016/j.fertnstert.2011.08.021
  13. Courtoy Guillaume E., Donnez Jacques, Marbaix Etienne, Dolmans Marie-Madeleine, In vivo mechanisms of uterine myoma volume reduction with ulipristal acetate treatment, 10.1016/j.fertnstert.2015.04.025
  14. Mutter George L, Bergeron Christine, Deligdisch Liane, Ferenczy Alex, Glant Mick, Merino Maria, Williams Alistair R W, Blithe Diana L, The spectrum of endometrial pathology induced by progesterone receptor modulators, 10.1038/modpathol.2008.19
  15. Horne Frances McFarland, Blithe Diana L., Progesterone receptor modulators and the endometrium: changes and consequences†, 10.1093/humupd/dmm023
  16. Williams A.R.W., Critchley H.O.D., Osei J., Ingamells S., Cameron I.T., Han C., Chwalisz K., The effects of the selective progesterone receptor modulator asoprisnil on the morphology of uterine tissues after 3 months treatment in patients with symptomatic uterine leiomyomata, 10.1093/humrep/dem026
  17. Williams Alistair R. W., Bergeron Christine, Barlow David H., Ferenczy Alex, Endometrial Morphology After Treatment of Uterine Fibroids With the Selective Progesterone Receptor Modulator, Ulipristal Acetate : , 10.1097/pgp.0b013e318251035b
  18. Fauser B, Obst Gynecol (2016)
  19. Chantraine Frederic, Poismans Gaelle, Nwachuku Julia, Bestel Elke, Nisolle Michelle, Expulsion of a uterine myoma in a patient treated with ulipristal acetate, 10.1002/ccr3.211
  20. Willame A, Eur Rev Med Pharmacol Sci, 20, 1439 (2016)
  21. Farquhar C.M., Lethaby A., Sowter M., Verry J., Baranyai J., An evaluation of risk factors for endometrial hyperplasia in premenopausal women with abnormal menstrual bleeding, 10.1016/s0002-9378(99)70487-4
  22. Anastasiadis PG, Eur J Gynaecol Oncol, 21, 131 (2000)
  23. Chabbert-Buffet Nathalie, Pintiaux-Kairis Axelle, Bouchard Philippe, Effects of the Progesterone Receptor Modulator VA2914 in a Continuous Low Dose on the Hypothalamic-Pituitary-Ovarian Axis and Endometrium in Normal Women: A Prospective, Randomized, Placebo-Controlled Trial, 10.1210/jc.2006-2816
  24. Chabbert-Buffet N, Mol Cel Endocrinol, 02, 21 (2012)
  25. Spitz Irving M., Mifepristone: where do we come from and where are we going?, 10.1016/j.contraception.2009.12.012
  26. Munro Malcolm G., Critchley Hilary O.D., Fraser Ian S., The FIGO classification of causes of abnormal uterine bleeding : Malcolm G. Munro, Hilary O.D. Crithcley, Ian S. Fraser, for the FIGO Working Group on Menstrual Disorders, 10.1016/j.ijgo.2011.01.001
  27. Huang YongMei, Jensen Jeffrey T., Brache Vivian, Cochon Leila, Williams Alistair, Miranda Maria-José, Croxatto Horacio, Kumar Narender, Sussman Heather, Hoskin Elena, Plagianos Marlena, Roberts Kevin, Merkatz Ruth, Blithe Diana, Sitruk-Ware Regine, A randomized study on pharmacodynamic effects of vaginal rings delivering the progesterone receptor modulator ulipristal acetate: research for a novel estrogen-free, method of contraception, 10.1016/j.contraception.2014.08.006